CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2018

Echocardiography for Tricuspid Valve Intervention

Essentials for understanding echocardiographic imaging in percutaneous tricuspid interventions.

By Menhel Kinno, MD, MPH; Sasan R. Raissi, MD; Jyothy J. Puthumana, MD; James D. Thomas, MD; and Charles J. Davidson, MD

cit | Article | July/August 2018

Considerations of Mitral and Tricuspid Transcatheter Therapies

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD

cit | News | October 13, 2011

PLC's US Pivotal Study of RenalGuard Approved

October 14, 2011—PLC Medical Systems, Inc. (Milford, MA) announced that it has received final approval from the US Food and Drug Administration to commence its United States pivotal trial to study the efficacy of the company's RenalGuard therapy and RenalGuard system for the prevention of contrast-induced nephropathy.

cit | News | January 22, 2012

US Pivotal Trial of PLC's RenalGuard Begins Enrollment

January 23, 2012—PLC Medical Systems, Inc. (Milford, MA) announced the start of enrollment in the CIN-RG trial, the company's pivotal trial in the United States to study the efficacy of its RenalGuard Therapy and RenalGuard System in the prevention of contrast-induced nephropathy (CIN).

Advertisement

Advertisement

cit | Article | July/August 2021

Treatment Options and Outcomes for Tricuspid Regurgitation

An update on the rapidly evolving landscape of surgical and transcatheter techniques and devices for tricuspid valve disease treatment.

By Gorav Ailawadi, MD, MBA; Charles Davidson, MD; Maurizio Taramasso, MD, PhD; and Marta Sitges Carreño, MD, PhD


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button